Telomere paradox: cancer risk vs. delayed senescence | Elissa Epel
Telomerase, an enzyme that extends the length of telomeres, is critical to healthy cellular aging. But having too much telomerase – as in the case of cancer cells – can be a bad thing. Cancer cells exploit the regenerative capacity of telomerase to perpetually divide, essentially becoming immortal. In this clip, Dr. Elissa Epel discusses how having an optimal ratio of telomerase – high enough to reduce the risk of chronic disease, but low enough to reduce the risk of cancer – is key.
Member support keeps us strong.
If you enjoy the fruits of , you can participate in helping us to keep improving it. Creating a pay-what-you-can subscription does just that! Plus, we throw in occasional member perks and, more importantly, churn out the best possible content without concerning ourselves with the wishes of any dark overlords.
Our website is 100% supported by people like you through this pay-what-you-can mechanism.
Fundamentals$15 / month
Loyal Fan$25 / month
Super Fan$50 / month
Power Supporter$125 / month
Heroic Supporter$250 / month